JeNu Biosciences Inc — Form D/A
JeNu Biosciences Inc of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2012-04-20. The offering totals $3.4M, of which $3.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2012-04-20
- Form: D/A
- Accession: 0001507477-12-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $3.4M
- Amount sold: $3.4M
- Minimum investment: $50K
- Investors: 7
- Date of first sale: 2011-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-171494
Issuer
- Name: JeNu Biosciences Inc
- CIK: 0001507477
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1101 N. NORTHLAKE WAY, SEATTLE, WA, 98103
- Phone: 866-565-5368
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Justin Reed | Director | Arlington Heights, IL |
| Wayne Wager | Director | Seattle, WA |
| Collette Courtion | Executive Officer | Seattle, WA |
| Wayne Wager | Executive Officer | Seattle, WA |
| G. Scott Greenburg | Executive Officer | KIRKLAND, WA |
| Pete Higgins | Director | Durham, NC |
| Colette Courtion | Executive Officer | Seattle, WA |
| Michael Slade | Director | San Mateo, CA |
| Michael Lau | Director | Bothell, WA |
| Cindy Crawford | Director | Seattle, WA |
| Alex Lebedev | Director | Seattle, WA |
| Peter Higgins | Director | Seattle, WA |
Other filings by this issuer (4)
More